echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Natural Products News > Shocked! CoVID-19 male mortality rate is 2.5 times higher than female!

    Shocked! CoVID-19 male mortality rate is 2.5 times higher than female!

    • Last Update: 2020-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    May 10, 2020 / / - COVID-19 is erupting around the world, with health care workers, policymakers and ordinary people struggling.
    we still don't fully understand why some people are more severely affected by viruses than others.
    , older people and those with certain existing conditions appear to be at greater risk.
    study, published in frontiers in Public Health, an open-access journal, examined gender differences in COVID-19 patients for the first time.
    study found that men and women were the same likely to be infected with the virus, but men were significantly more likely to be severely affected by the disease and die.
    suggest that older men or those with potential risk factors may need additional care.
    : Although most PATIENT-19 patients have milder symptoms, identifying factors that make them vulnerable to serious illness and death can help protect society and treat those most at risk.
    so far, researchers have confirmed that older COVID-19 patients, as well as those with certain underlying diseases such as heart and respiratory diseases, are at greater risk of serious illness and death.
    , Jin-Kui Yang, a physician at Tongren Hospital in Beijing, China, notes a trend among patients who die from COVID-19.
    , we noticed that the number of men dying from COVID-19 appeared to be higher than that of women, " says Dr. Yang.
    raises the question: Are men more likely to develop or die from COVID-19? We found that no one measured the gender differences in COVID-19 patients, so we started the survey.
    Yang and a team of colleagues analyzed data sets for several patients to see if there was a difference in how men and women responded to COVID-19.
    data include data on 43 treated patients and public data on 1,056 COVID-19 patients.
    virus that causes COVID-19 is similar to the one that broke out in SARS in 2003 and adheres to the same protein called ACE2 on the cells it attacks.
    the similarities, doctors also analyzed data sets of 524 SARS patients in 2003.
    coVID-19 patients, the researchers confirmed that older people and those with specific underlying diseases tend to have more serious illnesses and are more likely to die.
    age and number of infected men and women are similar, but men tend to have more serious diseases.
    notable is that in the largest COVID-19 database, more than 70 per cent of deaths are among men, meaning that men's mortality rate is almost 2.5 times that of women.
    interesting is that men, regardless of age, are important risk factors for worsening the severity of the disease.
    a 2003 SARS data set, researchers found a similar trend, with male mortality significantly higher than female mortality.
    interestingly, the protein ACE2 attacked by SARS and COVID-19 viruses had higher levels in men, cardiovascular disease, and diabetics, all of which had poorer results in COVID-19.
    , however, further research is needed to determine why male patients with COVID-19 perform worse than female patients.
    although the current study has a small sample size and requires larger studies to confirm the results, this is the first preliminary indication that male sex is an important risk factor for COVID-19 severity and death.
    study may be important for patient care.
    Yang said: "We recommend that for elderly male patients, additional supportive care and timely access to intensive care units are necessary.
    " () Reference: COVID-19 study show that men have over double the death rate of women Jian-Min Jin et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front. Public Health, 29 April 2020. https://doi.org/10.3389/fpubh.2020.00152.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.